Biological E's Covid-19 vaccine CORBEVAX gets WHO emergency use listing
HYDERABAD: Vaccine maker Biological E Limited (BE) on Tuesday said its Covid-19 vaccine CORBEVAX has received emergency use listing (EUL) from the World Health Organisation (WHO).
CORBEVAX, which was India’s first indigenously developed Covid-19 vaccine based on the protein sub-unit platform, was approved in India for restricted use in emergency for adults, adolescents as well as young children as well as a heterologous booster dose for those aged 18 years and above in India.
